Health & Environmental Research Online (HERO)


Print Feedback Export to File
2061997 
Journal Article 
ALUMINUM OVERLOAD IN RENAL-FAILURE PATIENTS AND ITS CLEARANCE FROM TISSUES AFTER KIDNEY-TRANSPLANTATION 
Fernandez, MD; Wrobel, K; Defrancisco, ALM; Sanzmedel, A 
1994 
Trace Elements and Electrolytes
ISSN: 0946-2104 
BIOSIS/95/00041 
11 
192-198 
eng 
BIOSIS COPYRIGHT: BIOL ABS. Aluminum levels in serum, bone and muscle samples have been evaluated using electrothermal atomic absorption spectrometry technique (ETA-AAS) and the values compared for control (non-uremic) subjects and renal failure patients undergoing regular dialysis treatment. As expected, elevated levels of aluminum in serum (63.8 | 34.3 mug/l) and in bone (29.1 | 16.9 mug/g) were observed in renal failure patients as compared with the corresponding average levels found in control population (9.0 | 1.1 mug/l, 7.1 | 0.4 mug/g respectively). No significative changes in muscle aluminum content were observed between the two groups of subjects under study: 5.9 | 0.5 mug/g for renal failure patients and 5.8 | 2.8 mug/g for the control samples. It appears that only bone aluminum levels correlated with the total amount of aluminum hydroxide ingested (r = 0.5607, p 0.05) by uremic patients to balance their Pa ratio. The effect of kidney transplantation on serum and urine aluminum cont 
ALUMINUM; SERUM; URINE; BONE; MUSCLE; KIDNEY TRANSPLANTATION; ELECTROTHERMAL ATOMIC ABSORPTION SPECTROMETRY